Pomerantz Law Firm Urges Reckitt Investors with Losses to Join Class Action Before Upcoming Deadlines

Pomerantz Law Firm Issues Investor Alert for Reckitt Benckiser Group

The Pomerantz Law Firm has announced the filing of a class action lawsuit against Reckitt Benckiser Group Plc, known simply as Reckitt. Investors who have experienced financial losses due to their investments in Reckitt are encouraged to take immediate action and connect with the firm. The lawsuit centers on allegations of securities fraud and other unlawful business practices purportedly committed by Reckitt and certain officers and directors of the company.

This action was officially filed in response to developments that have adversely impacted Reckitt's stock prices, particularly following recent jury verdicts against related subsidiaries. For instance, on March 15, 2024, the company’s Mead Johnson unit received a $60 million verdict after a jury held it negligent for failing to warn that its cow’s milk-based formula could significantly increase the risk of necrotizing enterocolitis (NEC) in preterm infants. This negative announcement caused Reckitt's American Depositary Share (ADS) price to decrease significantly, demonstrating how legal challenges can have tangible effects on stock value.

Investors are reminded that they have until August 4, 2025, to request their appointment as Lead Plaintiff. Individuals interested in joining the lawsuit should reach out to Danielle Peyton at Pomerantz through the provided contact details to ensure their participation. It is vital for affected investors to specify their purchase details, including the number of shares bought, to facilitate the claims process. The firm's website also allows interested parties to obtain a copy of the complaint.

The recent trends in litigation involving Reckitt have raised serious concerns among shareholders. Following another lawsuit verdict in July 2024 against Abbott Laboratories which revealed similar allegations regarding NEC risks associated with baby formula, Reckitt’s stock saw another drop, further complicating the financial landscape for investors. These developments highlight the pressing need for affected investors to act swiftly to protect their interests.

Founded by the esteemed Abraham L. Pomerantz, who is renowned for pioneering the field of securities class actions, Pomerantz LLP stands as a leading player in corporate, securities, and antitrust class litigation. Their commitment to championing the rights of investors over the past 85 years has yielded substantial recoveries for those affected by corporate fraud and mismanagement.

As the class action progresses, it is crucial for shareholders of Reckitt to remain informed of any updates regarding the lawsuit as these events unfold. The firm is dedicated to continuing this tradition of fighting for justice on behalf of victims of securities fraud and other corporate wrongdoings. Investors looking for updates or further information about the case are encouraged to visit www.pomerantzlaw.com.

Contact Information:
Danielle Peyton
Pomerantz LLP
Email: [email protected]
Phone: 646-581-9980 ext. 7980

This press announcement serves to inform and caution investors of the upcoming legal proceedings as they pursue their claims against Reckitt Benckiser Group Plc. Timing is essential to ensure that their voices are heard in court.